Search results
on breast implant illness (BII), breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), and breast implant–associated squamous cell carcinoma (BIA-SCC). BII is a constellation of systemic symptoms that can occur after breast implant devices are surgically implanted into the human body. BIA-ALCL is a T-cell lymphoma associ-
30 mar 2021 · Introduction: An increasing pool of literature proposes a link between silicone implants and autoimmune-related symptoms known colloquially as breast implant illness (BII).
16 lut 2020 · While physicians aim to treat these physical symptoms, currently the evidence supports the safety of silicone breast implants. This article entitled “Breast implant illness: a topic in review” presents an up-to-date review focusing on the safety of silicone breast implants.
24 kwi 2023 · This paper presents three patients believed to be suffering from breast implant illness, who after en-bloc resection, experienced resolution of their symptoms.
2 kwi 2023 · Breast implants have been associated with autoimmunity and other systemic symptoms for over 60 years. The terms for the symptoms have been labeled many things and only recently have they been referred to as breast implant illness (BII). BII remains a poorly defined and controver-sial complication.
Background Breast implant illness (BII) is a clinical disease defined by a constellation of symptoms that patients experience as a result of their breast implants. This retrospective, cohort study evaluated the benefit of breast implant explantation with total capsulectomy on patients’ symptoms.
women with breast implants report experiencing a myriad of disabling and distressing physical and psychological symp- toms attributed to their implants. Social media groups have coined the condition “breast implant illness” (BII).
